Pallas Capital Advisors LLC Pa Vmed Inc. Transaction History

Pallas Capital Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$0.22 - $0.5 $3,520 - $8,000	16,000 Added 33.17%	64,239 $19,000
Q2 2023 Jul 26, 2023	SELL	$0.35 - $0.56 $35 - $56	-100 Reduced 0.21%	48,239 $19,000
Q1 2023 May 02, 2023	SELL	$0.36 - $0.63 $11,412 - $19,971	-31,700 Reduced 39.61%	48,339 $17,000
Q3 2022 Nov 07, 2022	BUY	$0.57 - $34.65 $142 - $8,662	250 Added 0.31%	80,039 $95,000
Q1 2022 Apr 20, 2022	BUY	$1.16 - $2.5 $13,687 - $29,500	11,800 Added 17.36%	79,789 $85,000
Q4 2021 Feb 01, 2022	SELL	$2.46 - $8.74 $49,200 - $174,800	-20,000 Reduced 22.73%	67,989 $107,000
Q3 2021 Nov 12, 2021	BUY	$5.1 - $9.39 $184,563 - $339,814	36,189 Added 69.86%	87,989 $484,000
Q2 2021 Aug 11, 2021	BUY	$3.95 - $6.88 $86,110 - $149,984	21,800 Added 72.67%	51,800 $362,000
Q1 2021 May 14, 2021	BUY	$2.01 - $5.55 $60,299 - $166,500	30,000 New	30,000 $121,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $81.9M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pallas Capital Advisors LLC with notifications on news.